Roivant Sciences (ROIV) Net Cash Flow (2020 - 2025)

Roivant Sciences' Net Cash Flow history runs 6 years deep, the most recent figure standing at -$1.2 billion for Q4 2025.

• Quarterly Net Cash Flow rose 72.76% year-over-year to -$1.2 billion in Q4 2025, while the trailing twelve-month figure through Mar 2026 was -$2.7 billion (up 70.03% YoY) and the FY2026 annual result came in at -$1.3 billion, up 66.06% from the prior year.
• Net Cash Flow was -$1.2 billion for Q4 2025 at Roivant Sciences, down from -$2.7 million in the prior quarter.
• Across five years, Net Cash Flow topped out at $5.0 billion in Q4 2023 and bottomed at -$4.6 billion in Q4 2024.
• A 5-year average of -$507.4 million and a median of -$242.4 million in 2023 frame the typical range for Net Cash Flow.
• Annual changes were most pronounced in 2023 — Net Cash Flow soared 1036.57% — and 2024, when it tumbled 14574.37%.
• Roivant Sciences' Net Cash Flow stood at $84.5 million in 2021, then sank by 731.07% to -$533.0 million in 2022, then surged by 1036.57% to $5.0 billion in 2023, then plunged by 191.15% to -$4.6 billion in 2024, then surged by 72.76% to -$1.2 billion in 2025.
• Business Quant data shows ROIV's Net Cash Flow at -$1.2 billion in Q4 2025, -$2.7 million in Q3 2025, and -$1.5 billion in Q2 2025.